| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/CXO.12581 |
| P698 | PubMed publication ID | 28815736 |
| P50 | author | Nicole Carnt | Q48030073 |
| Fiona Stapleton | Q92509155 | ||
| P2093 | author name string | Chameen Samarawickrama | |
| Andrew White | |||
| P2860 | cites work | Contact lens referrals to Hull Royal Infirmary Ophthalmic A&E Unit | Q45840678 |
| Signs, symptoms, and comorbidities in contact lens-related microbial keratitis. | Q46166064 | ||
| The risk of microbial keratitis with overnight corneal reshaping lenses | Q46211585 | ||
| The Glenn A. Fry award lecture 2005. The pathogenesis of contact lens-related keratitis. | Q46409820 | ||
| A longitudinal study of trends in keratitis in Australia | Q46774911 | ||
| Effects of daily irrigation on corneal epithelial permeability and adverse events with silicone hydrogel contact lens continuous wear | Q46813980 | ||
| Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis | Q46928222 | ||
| Acanthamoeba keratitis: the persistence of cases following a multistate outbreak | Q47405846 | ||
| Risk factors for microbial keratitis with contemporary contact lenses: a case-control study | Q47597233 | ||
| The incidence of contact lens-related microbial keratitis in Australia | Q47656218 | ||
| Referral pathways and management of contact lens-related microbial keratitis in Australia and New Zealand. | Q47772632 | ||
| Incidence of contact-lens-associated microbial keratitis and its related morbidity. | Q50650047 | ||
| Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. | Q50701464 | ||
| Population-based cohort study of microbial keratitis in Scotland: incidence and features. | Q50772988 | ||
| Development and evaluation of evidence-based guidelines on contact lens-related microbial keratitis. | Q50857921 | ||
| Bacterial adhesion to conventional hydrogel and new silicone-hydrogel contact lens materials. | Q50869884 | ||
| Which is more important to the initiation of contact lens related microbial keratitis, trauma to the ocular surface or bacterial pathogenic factors? | Q51146285 | ||
| Imprinted soft contact lenses as norfloxacin delivery systems. | Q51180391 | ||
| Bacterial populations on silicone hydrogel and hydrogel contact lenses after swimming in a chlorinated pool. | Q51540546 | ||
| Ocular complications associated with the use of cosmetic contact lenses from unlicensed vendors. | Q51813069 | ||
| Herpes Simplex Keratitis: Bilateral Effects. | Q53401427 | ||
| "Chemical nose" for the visual identification of emerging ocular pathogens using gold nanostars. | Q53530200 | ||
| Association of single nucleotide polymorphisms of interleukins-1β, -6, and -12B with contact lens keratitis susceptibility and severity. | Q54314695 | ||
| Clinical Efficacy of Moxifloxacin in the Treatment of Bacterial Keratitis | Q57245038 | ||
| Medical interventions for acanthamoeba keratitis | Q24187990 | ||
| Topical corticosteroids as adjunctive therapy for bacterial keratitis | Q24193096 | ||
| Defining and measuring gender: a social determinant of health whose time has come. | Q24815093 | ||
| Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis | Q28256922 | ||
| Responses of Pseudomonas aeruginosa to antimicrobials | Q28305587 | ||
| Hypoxia, overnight wear, and tear stagnation effects on the corneal epithelium: data and proposed model | Q31135017 | ||
| Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. | Q31857855 | ||
| Vertical movement of epithelial basal cells toward the corneal surface during use of extended-wear contact lenses | Q33186148 | ||
| The RPS adeno detector for diagnosing adenoviral conjunctivitis | Q33258979 | ||
| Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the Steroids for Corneal Ulcers Trial show elevated resistance to fluoroquinolones | Q33559958 | ||
| Diagnostic accuracy of microbial keratitis with in vivo scanning laser confocal microscopy. | Q33600830 | ||
| National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States | Q33628705 | ||
| Topical steroids in the treatment of central and paracentral corneal ulcers | Q33648265 | ||
| Risk factors in microbial keratitis leading to penetrating keratoplasty | Q33656085 | ||
| Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers | Q33895429 | ||
| Superior epithelial arcuate lesions with soft contact lens wear | Q34171719 | ||
| Early addition of topical corticosteroids in the treatment of bacterial keratitis | Q34240730 | ||
| Risk factors for corneal infiltrative events during continuous wear of silicone hydrogel contact lenses | Q34701941 | ||
| Differential diagnosis of microbial keratitis and contact lens-induced peripheral ulcer | Q35139029 | ||
| Noninflammatory silicone hydrogel contact lens complications | Q35139093 | ||
| Simplifying collection of corneal specimens in cases of suspected bacterial keratitis. | Q35156428 | ||
| Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases | Q35156993 | ||
| Clinical characterization of corneal infiltrative events observed with soft contact lens wear. | Q35162832 | ||
| Disposable contact lens use as a risk factor for microbial keratitis | Q35302967 | ||
| Acanthamoeba keratitis: multicentre survey in England 1992-6. National Acanthamoeba Keratitis Study Group | Q35303382 | ||
| Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh | Q35306400 | ||
| Doxycycline in the management of pseudomonas corneal melting: two case reports and a review of the literature | Q35558016 | ||
| Current Perspectives on Ophthalmic Mycoses | Q35558829 | ||
| Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors | Q35589674 | ||
| Incidence of keratitis of varying severity among contact lens wearers | Q35593063 | ||
| Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment | Q35797204 | ||
| Contralateral Clinically Unaffected Eyes of Patients With Unilateral Infectious Keratitis Demonstrate a Sympathetic Immune Response | Q35806479 | ||
| Sustained ocular delivery of ciprofloxacin using nanospheres and conventional contact lens materials | Q35921444 | ||
| In vivo confocal microscopy in fungal keratitis | Q35953609 | ||
| The clinical diagnosis of microbial keratitis | Q35985795 | ||
| Microbial keratitis in overnight orthokeratology: review of the first 50 cases. | Q36257456 | ||
| The pathophysiology of Acanthamoeba keratitis | Q36405781 | ||
| Fungal keratitis: emerging trends and treatment outcomes | Q36651367 | ||
| Risk factors for contact lens-related microbial keratitis in Singapore. | Q36686774 | ||
| Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus | Q36702963 | ||
| Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review | Q36792487 | ||
| Corticosteroids for bacterial corneal ulcers | Q37076971 | ||
| Altered Patterns of Fungal Keratitis at a London Ophthalmic Referral Hospital: An Eight-Year Retrospective Observational Study | Q37158706 | ||
| The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole | Q37160745 | ||
| The association of contact lens solution use and Acanthamoeba keratitis | Q37217542 | ||
| Use of Corticosteroids in Combination with Antimicrobial Drugs in the Treatment of Infectious Corneal Disease | Q37228593 | ||
| Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). | Q37315299 | ||
| Acanthamoeba keratitis: diagnosis and treatment update 2009. | Q37574514 | ||
| The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial | Q37625475 | ||
| Trends in fungal keratitis in the United States, 2001 to 2007. | Q37768963 | ||
| Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins. | Q37810333 | ||
| Adenovirus advances: new diagnostic and therapeutic options | Q37871299 | ||
| Diagnostic and therapeutic considerations in fungal keratitis | Q37928321 | ||
| Recent advances in ocular drug delivery | Q38059884 | ||
| Collagen cross-linking and corneal infections | Q38109085 | ||
| Therapeutic and optical keratoplasty in the management of Acanthamoeba keratitis: risk factors, outcomes, and summary of the literature | Q38254911 | ||
| Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial | Q38385726 | ||
| Ocular delivery systems for topical application of anti-infective agents | Q38577846 | ||
| A proof-of-concept model for the identification of the key events in the infection process with specific reference to Pseudomonas aeruginosa in corneal infections. | Q38627617 | ||
| Seasonal Variation in the Presentation of Infectious Keratitis | Q38653155 | ||
| Strategies for the prevention of contact lens-related Acanthamoeba keratitis: a review | Q38675542 | ||
| Practice patterns and opinions in the treatment of acanthamoeba keratitis. | Q39215509 | ||
| Trial of chlorhexidine gluconate for fungal corneal ulcers | Q39378443 | ||
| Pathogenesis and treatment of "sterile" midperipheral corneal infiltrates associated with soft contact lens use. | Q39424376 | ||
| Characteristic clinical features as an aid to the diagnosis of suppurative keratitis caused by filamentous fungi. | Q39521544 | ||
| Effects of Eyelid Closure and Disposable and Silicone Hydrogel Extended Contact Lens Wear on Rabbit Corneal Epithelial Proliferation | Q39647953 | ||
| Activities of therapeutic agents and myristamidopropyl dimethylamine against Acanthamoeba isolates | Q39651850 | ||
| Strategies for the management of microbial keratitis | Q39711956 | ||
| Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial | Q39968940 | ||
| Risk Factors for Acanthamoeba Keratitis-A Multistate Case-Control Study, 2008-2011. | Q40367400 | ||
| Assessment of biofilm formation of E. meningoseptica, D. acidovorans, and S. maltophilia in lens cases and their growth on recovery media | Q40526484 | ||
| The Impact of Topical Corticosteroids Used in Conjunction with Antiamoebic Therapy on the Outcome of Acanthamoeba Keratitis | Q40764114 | ||
| Relationship of Virulence Factors and Clinical Features in Keratitis Caused by Pseudomonas aeruginosa | Q40930887 | ||
| Impression membrane for the diagnosis of microbial keratitis | Q40996033 | ||
| Nontuberculous Mycobacterial Ocular Infections: A Systematic Review of the Literature | Q41142635 | ||
| Correlation of Pseudomonas aeruginosa genotype with antibiotic susceptibility and clinical features of induced central keratitis | Q41583816 | ||
| Pharmacological treatment for infectious corneal ulcers | Q42273313 | ||
| High-oxygen-transmissibility soft contact lenses do not induce limbal hyperaemia. | Q42663414 | ||
| Epidemiology of Pseudomonas aeruginosa keratitis in contact lens wearers | Q43082182 | ||
| Medical management approach to infectious keratitis | Q43187227 | ||
| Emerging prevalence of microsporidial keratitis in Singapore: epidemiology, clinical features, and management | Q43264952 | ||
| Bacterial biofilm on contact lenses and lens storage cases in wearers with microbial keratitis | Q43471952 | ||
| Higher risk taking propensity of contact lens wearers is associated with less compliance | Q43512495 | ||
| Do swimming goggles limit microbial contamination of contact lenses? | Q43650469 | ||
| Effects of rigid and soft contact lens daily wear on corneal epithelium, tear lactate dehydrogenase, and bacterial binding to exfoliated epithelial cells. | Q43653245 | ||
| Microbial keratitis as a foreseeable complication of cosmetic contact lenses: a prospective study | Q43659372 | ||
| Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution | Q43665915 | ||
| Risk factors for contact lens-related fusarium keratitis: a case-control study in Singapore | Q43809837 | ||
| Topical cyclosporin A in the management of therapeutic keratoplasty for mycotic keratitis | Q43893675 | ||
| Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts | Q43977488 | ||
| Factors affecting the morbidity of contact lens-related microbial keratitis: a population study | Q43986080 | ||
| Risk factors for the development of corneal infiltrative events associated with contact lens wear | Q44179647 | ||
| Characteristics of and risk factors for contact lens-related microbial keratitis in a tertiary referral hospital. | Q44301245 | ||
| Fungal keratitis in the United Kingdom 2003-2005. | Q44384511 | ||
| Case-Control Pilot Study of Soft Contact Lens Wearers With Corneal Infiltrative Events and Healthy Controls | Q44446285 | ||
| Ophthalmic drug delivery through contact lenses | Q44956640 | ||
| Bacterial biofilm diversity in contact lens-related disease: emerging role of Achromobacter, Stenotrophomonas, and Delftia. | Q44975617 | ||
| IL-10 promotor haplotypes associated with susceptibility to and severity of bacterial corneal ulcers | Q45187785 | ||
| P577 | publication date | 2017-08-16 | |
| P1433 | published in | Clinical and Experimental Optometry | Q15767014 |
| P1476 | title | The diagnosis and management of contact lens-related microbial keratitis |
| Q64271503 | Contact lens-related visual loss in the context of microbial keratitis | cites work | P2860 |
Search more.